1.Inhibitory Effect of Ginsenoside Rg3 Combined With 5-Fluorouracil on Tumor Angiogenesis and Tumor Growth of Colon Cancer in Mice:An Experimental Study
Yashu ZHAO ; Licong DENG ; Yue CAO ; Buyun MA ; Yue LI ; Jingyi XU ; Hong LI ; Ying HUANG
Journal of Sichuan University (Medical Sciences) 2024;55(1):111-117
Objective To evaluate the inhibitory effect of ginsenoside Rg3 combined with 5-fluorouracil(5-FU)on tumor angiogenesis and tumor growth in colon cancer in mice.Methods CT26 mouse model of colon cancer was established and the mice were randomly assigned to the control group,the ginsenoside Rg3 group,the 5-FU group,and the Rg3 combined with 5-FU group.The 5-FU group was injected intraperitoneally at the dose of 20 mg/kg,0.2 mL/animal,and once a day for 10 days.Treatment for the Rg3 group was given at the dose of 20 mg/kg,0.2 mL/animal,and once a day for 21 days via gastric gavage.The dose and the mode of treatment for the Rg3+5-FU combination group were the same as those for the 5-FU and the Rg3 group.The control group was intraperitoneally injected with 0.2 mL/d of normal saline for 10 days.The expression of vascular endothelial growth factor(VEGF)and CD31 and the microvascular density(MVD)of the tumor tissues were examined by immunohistochemistry.The blood flow signals and tumor necrosis were examined by color Doppler flow imaging(CDFI).The quality of life,survival rate,tumor volume,tumor mass,and tumor inhibition rate of the mice were monitored.Results After 21 days of treatment,the tumor volume and the tumor mass of all treatment groups were significantly decreased compared with those the control group,with the combination treatment group exhibiting the most significant decrease.The tumor inhibition rates of the Rg3 group,the 5-FU group,and the combination group were 29.96%,68.78%,and 73.42%,respectively.Rg3 treatment alone had inhibitory effect on tumor growth to a certain degree,while 5-FU treatment alone or 5-FU combined with Rg3 had a stronger inhibitory effect on tumor growth.The tumor inhibition rate of the combination group was higher than that of the 5-FU group,but the difference was not statistically significant(P>0.05).Color Doppler ultrasound showed that there were multiple localized and large tumor necrotic areas that were obvious and observable in the Rg3 group and the combination group,and that there were only small tumor necrotic areas in the 5-FU group and the control group.The tumor necrosis rate of the combination group was(55.63±3.12)%,which was significantly higher than those of the other groups(P<0.05).CDFI examination of the blood flow inside of the tumor of the mice showed that the blood flow signals in the combination group were mostly grade 0-Ⅰ,and that the blood flow signals in the control group were the most abundant,being mostly grade Ⅱ-Ⅲ.The abundance of the blood flow signals in the Rg3 and 5-FU groups were between those of the control group and the combination group.Compared with those of the control group,the expression levels of MVD and VEGF in the tumor tissues of the Rg3 group,the 5-FU group,and the combination group were significantly decreased,with the combination group showing the most significant decrease(P<0.05).HE staining results indicated that there was significant tumor necrosis in mice in the control group and that there were more blood vessels.In contrast,in the tumor of the Rg3 group and the 5-FU group,there were fewer blood vessels and necrotic gaps appeared within the tumors.In the combination group,the tumor tissues had the fewest blood vessels and rope-like necrosis was observed.The mice started dying on the 18th day after treatment started,and all the mice in the control group died on the 42nd day.By this time,there were 3,5,and 7 mice still alive in the Rg3 group,the 5-FU group,and the combination group,respectively,presenting a survival rate of 30%,50%,and 70%,respectively.All mice in all the groups died on day 60 after treatment started.Conclusion Ginsenoside Rg3 combined with 5-FU can significantly inhibit tumor angiogenesis and tumor growth of colon cancer in mice and improve the survival and quality of life of tumor-bearing mice.
2.Dietary intervention for the treatment of psoriasis
Liping JIN ; Wu ZHU ; Yan LU ; Panpan LIU ; Minjia TAN ; Ying WANG ; Jing YANG ; Licong XU ; Kun HU ; Yehong KUANG
Chinese Journal of Dermatology 2023;56(4):357-360
This review summarizes dietary characteristics of patients with psoriasis, discusses effects of gluten-free diet, Mediterranean diet and dietary intervention-induced weight loss on psoriasis, and analyzes the efficacy of dietary supplements in the treatment of psoriasis, such as fish oil, vitamin D, vitamin B12, selenium, and probiotics.
3.Efficacy and safety of anti-PD-1 monoclonal antibody in advanced hepatocellular carcinoma after TACE combined with TKI therapy
Zining XU ; Jingjun HUANG ; Juan ZHOU ; Wensou HUANG ; Yongjian GUO ; Mingyue CAI ; Jingwen ZHOU ; Liteng LIN ; Licong LIANG ; Kangshun ZHU
Chinese Journal of Internal Medicine 2021;60(7):630-636
Objective:To evaluate the efficacy and safety of anti-programmed cell death 1 (PD-1) receptor monoclonal antibody (MoAb) in patients with advanced hepatocellular carcinoma (HCC) after treatment of transcatheter arterial chemoembolization (TACE) combined with tyrosine kinase inhibitor (TKI).Methods:From February 2019 to February 2020, 56 HCC patients who relapsed after TACE-TKI treatment in Department of Interventional Radiology, The Second Affiliated Hospital of Guangzhou Medical University were enrolled. All patients received anti-PD-1 MoAb (sintilimab injection) and followed up every 6 weeks. According to mRECIST, the curative effect was evaluated as complete response (CR), partial response (PR), stable disease (SD) or progressive disease (PD). Objective response rate (ORR) and disease control rate (DCR), progression-free survival (PFS) and treatment-related adverse events (TRAEs) were recorded. Univariate analysis by Chi-square test and binary logistic regression model was used to determine the influencing factors of DCR. The Kaplan-Meier method and Cox proportional hazard regression model were used to analyze the survival data.Results:A total of 48 patients were enrolled in this study including 42 males and 6 females, with a median age of 55 years (29-71 years). ECOG scores comprised of 0 in 24 cases, 1-2 in 24 cases. Thirty-six patients were in Child-Pugh grade A of liver function and 12 cases were grade B. The median follow-up time was 4.5 months. There were 2 patients achieved CR, 12 patients with PR and 16 with SD. ORR was 29.2%, DCR was 62.5%. The independent influencing factors of DCR was ECOG score and AFP level ( P=0.031, P=0.012). Median PFS was 4.1 months (95% CI 2.7-5.4 months), and ECOG score was the independent influencing factor of PFS ( P=0.042). Treatment-related adverse events were reported in 70.8% (34/48) patients. Incidence of grade Ⅲ-Ⅳ TRAEs was 22.9% (11/48). Conclusion:In patients with HCC who relapse from TACE and TKI treatment, anti-PD-1 monoclonal antibody is efficacious safe especially in those with ECOG 0 score.
4.Estimation of postmortem interval by determination of K~+ concentration in aqueous humor
Guoli LV ; Yaping ZHOU ; Zhigang LI ; Xinshu XU ; Licong YU ; Xin WANG ; He SHI ; Chuanchao XU
Chinese Journal of Forensic Medicine 2010;25(1):24-26
Objective To investigate the applicability of the K~+ concentration in aqueous humor to estimate postmortem interval(PMI).Methods 30 White New-Zealand rabbit were sacrificed by air embolism and divided into 10 groups.Aqueous humor and vitreous humor were sampled at 0.5h,1h,3h,6h,8h,12h,16h,20h,and 24h after death.The concentration of potassium,sodium and calcium were analyzed by an autoanalyzer and the data were statistically processed by SPSS software for Windows.Results Increase in potassiam concentration in aqueous humor was correlated with the postmortem interval(R~2=0.956).Conclusion Measurement of potassium concentration in aqueous humor may be used for PMI estimation.

Result Analysis
Print
Save
E-mail